| 000 | 01678 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517164452.0 | ||
| 264 | 0 | _c20170905 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1474-1768 | ||
| 024 | 7 |
_a10.1038/nrc.2017.42 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYap, Timothy A | |
| 245 | 0 | 0 |
_aNovel insights into mesothelioma biology and implications for therapy. _h[electronic resource] |
| 260 |
_bNature reviews. Cancer _c07 2017 |
||
| 300 |
_a475-488 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aGPI-Linked Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGenes, Neurofibromatosis 2 |
| 650 | 0 | 4 | _aGenes, Tumor Suppressor |
| 650 | 0 | 4 | _aGenes, p16 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aMesothelin |
| 650 | 0 | 4 |
_aMesothelioma _xgenetics |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xprevention & control |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 |
_aProtein-Arginine N-Methyltransferases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTumor Microenvironment |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 650 | 0 | 4 |
_aUbiquitin Thiolesterase _xgenetics |
| 700 | 1 | _aAerts, Joachim G | |
| 700 | 1 | _aPopat, Sanjay | |
| 700 | 1 | _aFennell, Dean A | |
| 773 | 0 |
_tNature reviews. Cancer _gvol. 17 _gno. 8 _gp. 475-488 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrc.2017.42 _zAvailable from publisher's website |
| 999 |
_c27399046 _d27399046 |
||